Skip to main content

Table 3 Summary of Weight Outcomes

From: Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis

 

Weight Loss ≥ 2 kg

Weight gain ≥ 1 kg

 

At any time

Sustained to endpoint

At any time

Sustained to endpoint

Nizatidine study

(n = 67)

20.9% (n = 14)

7.5% (n = 5)

70.2% (n = 47)

59.7% (n = 40)

Sibutramine study(n = 42)

42.9% (n = 18)

26.2% (n = 11)

42.9% (n = 18)

19.1% (n = 8)

Amantadine study(n = 48)

39.6% (n = 19)

33.3% (n = 16)

56.3% (n = 27)

37.5% (n = 18)

  1. Only patients with at least 1 post-baseline measurement are included.
Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us